A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Human progesterone target tissues contain two progesterone receptors: B-receptors (hPRB), which are 933 amino acids in length, and A-receptors (hPRA), which lack the N-terminal 164 amino acids. The two isoforms differ functionally when they are occupied by agonists or antagonists. We postulated that the unique 164-amino acid, B-upstream segment (BUS) is in part responsible for the functional differences between the two isoforms and have constructed a series of hPR expression vectors encoding BUS fused to isolated down-stream functional domains of the receptors. These include the two transactivation domains: activation function-1 (AF1), located in a 90-amino acid segment just up-stream of the DNA-binding domain (DBD) and nuclear localization signal (NLS), and AF2, located in the hormone-binding domain. BUS is a highly phosphorylated domain, and contains the serine residues responsible for the hPRB triplet protein structure. The construct containing BUS-DBD-NLS binds tightly to DNA when aided by accessory nuclear factors. In HeLa cells, BUS-DBD-NLS strongly and autonomously activates transcription of chloramphenicol acetyltransferase (CAT) from a promoter containing two progesterone response elements (PRE2-TATAtk-CAT). Transcription levels with BUS-DBD-NLS are equivalent to those seen with full-length hPRB, and are higher than those seen with hPRA. BUS specifically requires an intact hPR DBD to be transcriptionally active. DBD mutants that cannot bind DNA or whose DNA binding specificity has been switched to an estrogen response element cannot cooperate in BUS transcriptional activity. The function of BUS-DBD-NLS is promoter and cell specific. It does not transactivate a CAT reporter driven by the mouse mammary tumor virus promoter in HeLa cells and poorly transactivates PRE2-TATAtk-CAT in PR-negative T47D breast cancer cells. However, in the breast cancer cells, BUS-DBD-NLS transactivation of PRE2-TATAtk-CAT can be reconstituted by either elevating cellular levels of cAMP or linking BUS and DBD to AF1 or AF2 of hPR, each of which alone is also inactive in these cells. We conclude that hPRB contains a unique third activation function (AF3) located within BUS and requiring the functional DBD of hPR. Depending on the promoter or cell tested, AF3 can activate transcription autonomously, or it can functionally synergize with AF1 or AF2. Autonomous AF3 function may explain the unexpected transactivating actions of antiprogestin-occupied hPRB, an issue of importance in hormone-resistant breast cancers and in tissue-specific agonist-like effects of hormone antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
How eukaryotic transcriptional activators work
Ptashne, M. (1988) · Nature · doi:10.1038/335683a0 · Cited by 1,825
Expression of a β-globin gene is enhanced by remote SV40 DNA sequences
Banerji, J., Rusconi, S., & Schaffner, W. (1981) · Cell · doi:10.1016/0092-8674(81)90413-x · Cited by 1,724
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
The regulation of transcription by phosphorylation
Hunter, T., & Karin, M. (1992) · Cell · doi:10.1016/0092-8674(92)90162-6 · Cited by 1,281
The human estrogen receptor has two independent nonacidic transcriptional activation functions
Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., & Chambon, P. (1989) · Cell · doi:10.1016/0092-8674(89)90031-7 · Cited by 1,048
Determinants of target gene specificity for steroid/thyroid hormone receptors
Umesono, K., & Evans, R. M. (1989) · Cell · doi:10.1016/0092-8674(89)90051-2 · Cited by 948
Functional domains of the human glucocorticoid receptor
Giguère, V., Hollenberg, S. M., Rosenfeld, M. G., & Evans, R. M. (1986) · Cell · doi:10.1016/0092-8674(86)90339-9 · Cited by 918
Cited by
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O'Malley, B. W. (1995) · Genes & Development · doi:10.1101/gad.9.18.2266 · Cited by 1,862
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P., & Conneely, O. M. (2000) · Science · doi:10.1126/science.289.5485.1751 · Cited by 704
Steroid hormone receptors: an update
Beato, M. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.3.225 · Cited by 614
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Horwitz, K. B., & Wolf, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110090200 · Cited by 572
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
Bethea, C. L., Lu, N. Z., Gundlah, C., & Streicher, J. M. (2002) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0225 · Cited by 490
Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. W., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.693 · Cited by 478
Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair
Gellersen, B., & Brosens, J. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780357 · Cited by 436
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
Reproductive Functions of Progesterone Receptors
Conneely, O. M. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.339 · Cited by 376
Giangrande, P. H., A. Kimbrel, E., Edwards, D. P., & McDonnell, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3102-3115.2000 · Cited by 376
Nuclear Receptor Structure: Implications for Function
Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D., & Miura, M. T. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160308 · Cited by 366
Steroid hormone receptors and their regulation by phosphorylation
WEIGEL, N. L. (1996) · Biochemical Journal · doi:10.1042/bj3190657 · Cited by 354
Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Patel, B., Elguero, S., Thakore, S., Dahoud, W., Bedaiwy, M., & Mesiano, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu056 · Cited by 353
Owen, G. I., Richer, J. K., Tung, L., Takimoto, G., & Horwitz, K. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10696 · Cited by 349
Ligand-independent activation of steroid hormone receptors
Weigel, N. L., & Zhang, Y. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050241 · Cited by 345
Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis
Wu, Y., Strawn, E., Basir, Z., Halverson, G., & Guo, S.-W. (2006) · Epigenetics · doi:10.4161/epi.1.2.2766 · Cited by 321
Brosens, J. J., Hayashi, N., & White, J. O. (1999) · Endocrinology · doi:10.1210/endo.140.10.7070 · Cited by 315
Lim, Y. C., Desta, Z., Flockhart, D. A., & Skaar, T. C. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0926-7 · Cited by 309
Wärnmark, A., Treuter, E., Wright, A. P. H., & Gustafsson, J.-A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0384 · Cited by 308
Shupnik, M. A. (2004) · Oncogene · doi:10.1038/sj.onc.1208076 · Cited by 301
Groshong, S. D., Owen, G. I., Grimison, B., Schauer, I. E., Todd, M. C., Langan, T. A., Sclafani, R. A., Lange, C. A., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.11.1593 · Cited by 299
He, B., Gampe, R. T., Kole, A. J., Hnat, A. T., Stanley, T. B., An, G., Stewart, E. L., Kalman, R. I., Minges, J. T., & Wilson, E. M. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.036 · Cited by 295
Wetendorf, M., & DeMayo, F. J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.028 · Cited by 285
Conneely, O. M., Mulac-Jericevic, B., & Lydon, J. P. (2003) · Steroids · doi:10.1016/s0039-128x(03)00126-0 · Cited by 277
Reproductive tissue selective actions of progesterone receptors
Mulac-Jericevic, B., & Conneely, O. M. (2004) · Reproduction · doi:10.1530/rep.1.00189 · Cited by 276
Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice
Conneely, O. M., Mulac-Jericevic, B., Lydon, J. P., & De Mayo, F. J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00465-8 · Cited by 255
Mote, P. A., Bartow, S., Tran, N., & Clarke, C. L. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014820500738 · Cited by 255
Ballaré, C., Uhrig, M., Bechtold, T., Sancho, E., Di Domenico, M., Migliaccio, A., Auricchio, F., & Beato, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1994-2008.2003 · Cited by 220
Hopp, T. A., Weiss, H. L., Hilsenbeck, S. G., Cui, Y., Allred, D. C., Horwitz, K. B., & Fuqua, S. A. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0141 · Cited by 220
De Vivo, I., Huggins, G. S., Hankinson, S. E., Lescault, P. J., Boezen, M., Colditz, G. A., & Hunter, D. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192172299 · Cited by 199
Scarpin, K. M., Graham, J. D., Mote, P. A., & Clarke, C. L. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07009 · Cited by 198
Molecular evidence of functional progesterone withdrawal in human myometrium
Nadeem, L., Shynlova, O., Matysiak-Zablocki, E., Mesiano, S., Dong, X., & Lye, S. (2016) · Nature Communications · doi:10.1038/ncomms11565 · Cited by 173
Mechanisms of progesterone action in inhibiting prematurity
Sfakianaki, A. K., & Norwitz, E. R. (2006) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050600949829 · Cited by 108
Progesterone production and actions in the human central nervous system and neurogenic tumors
Inoue, T., Akahira, J.-I., Suzuki, T., Darnel, A. D., Kaneko, C., Takahashi, K., Hatori, M., Shirane, R., Kumabe, T., Kurokawa, Y., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-012096 · Cited by 96
Nuclear receptor superfamily: Principles of signaling
Germain, P., Altucci, L., Bourguet, W., Rochette-Egly, C., & Gronemeyer, H. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111619 · Cited by 53
“Finally, the activation function(s) AF-1 display cell, DBD and promoter specificity [19–21], the origin of which is still elusive but may be related to the posttranslational modification [22] and cell-specific action and/or expression of AF-1 coactivators [23].”
BackgroundDeterminants of the heightened activity of glucocorticoid receptor translational isoforms
Bender, I. K., Cao, Y., & Lu, N. Z. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1009 · Cited by 19
Metadata
- Authors
- Sartorius, C. A.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1994-10-01
- Volume
- 8
- Issue
- 10
- Pages
- 1347-1360
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W1983261302
- Cited by
- 342
- References
- 40
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.